Cargando…
Diagnosis of Parkinson's disease by investigating the inhibitory effect of serum components on P450 inhibition assay
Parkinson’s disease (PD) is the second most common neurodegenerative disease, and diagnostic methods and biomarkers for patients without subjective motor symptoms have not yet been established. Previously, we developed a cytochrome P450 inhibition assay that detects alterations in metabolite levels...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033851/ https://www.ncbi.nlm.nih.gov/pubmed/35459262 http://dx.doi.org/10.1038/s41598-022-10528-x |